Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001233162 | SCV001405744 | likely benign | Noonan syndrome 9 | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004033192 | SCV004052296 | uncertain significance | Cardiovascular phenotype | 2023-07-19 | criteria provided, single submitter | clinical testing | The c.3407T>C (p.L1136S) alteration is located in exon 22 (coding exon 22) of the SOS2 gene. This alteration results from a T to C substitution at nucleotide position 3407, causing the leucine (L) at amino acid position 1136 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |